Large-scale testing (Phase 3)Study completedNCT00750880
What this trial is testing
An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,681